spacer
home > ebr > spring 2018 > rules for success
PUBLICATIONS
European Biopharmaceutical Review

Rules for Success

Over the past 40 years, the role of regulatory professionals has changed immensely. Factors such as the rapid pace of technological innovation, heightened global safety issues, and different and changing regulatory environments are just a few of the challenges that influence the regulatory landscape and, in turn, shape the profession.

In those years, some regulatory societies have seen their membership evolve as the dynamics of the profession have pivoted to meet regulatory and strategic demands. Membership has transformed from a collection of individuals from varied fields, tasked with the administrative aspects of a growing body of requirements, to a group of professionals who engage with the entire product lifecycles of their respective organisations. Regulatory teams link science, technology, and innovation with clinical needs and maintain a watchful eye on compliance and developments, policy, and good business practice.

This article discusses the evolving role of regulatory within the pharmaceutical industry, the importance of having a competent workforce, and how this profession can be a strategic driver of organisational success.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr William Bridges joined the Regulatory Affairs Professionals Society as Vice President of Education and Professional Development in January 2017. In his 20 years of experience, he has designed instructional materials and curriculum, created a vision for education and training programmes, and developed competency-guided roadmaps for learners in the military, academia, government, and association spheres. He also holds a PhD in history from the University of Nebraska, US and has taught for the University of Nebraska, US, Towson University, US, and the American public university system.
spacer
Dr William Bridges
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Companyís novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers

galenIQ - The smart excipient

BENEO GmbH

galenIQ combines a multitude of outstanding characteristics and is suitable for a wide range of pharmaceutical applications. galenIQ can be used as more than just a bulk excipient. It also serves as an anti-caking agent, anti-humectant agent, stabilizer or oral care and taste agent to mention just a few additional functions.
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Irelandís premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement